Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Trivello

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia|May 1, 1983
[Etiopathogenesis of measles infection]R Trivello
L'Igiene Moderna|January 1, 1970
[A spectrophotometric method for determination of fluorine in urine]G Rausa, R Trivello
Bollettino Dell'Istituto Sieroterapico Milanese|March 31, 1977
Complement fixing antibody to varicella-zoster virus in different age groups and after zosterM E Moschen, A Peserico, R Trivello
Current Pharmaceutical Design|August 5, 2008
Epidemiology of HCV infectionV Baldo, T Baldovin, R Trivello, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1975
[Seroepidemiologic research on the antipoliomyelitic immunity in adult unvaccinated subjects]R Trivello, M E Moschen, M Romano, et al.
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia|November 1, 1977
[Characteristics of the complement-fixing antibody response for varicella-zoster virus in patients with herpes zoster]R Trivello, A Peserico, M E Moschen, et al.
Gerontology|June 22, 2000
Prevalence of antibodies against hepatitis C virus in the elderly: a seroepidemiological study in a nursing home and in an open population. The Collaborative GroupV Baldo, A Floreani, T Menegon, et al.
Vaccine|May 12, 2001
Comparison of three different influenza vaccines in institutionalised elderlyV Baldo, T Menegon, C Bonello, et al.
Journal of Clinical Immunology|May 22, 2007
Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseasesV Baldo, T Baldovin, A Floreani, et al.
Vaccine|March 27, 2007
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complicationsV Baldo, T Baldovin, A Floreani, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia|May 1, 1983
[Etiopathogenesis of measles infection]R Trivello
L'Igiene Moderna|January 1, 1970
[A spectrophotometric method for determination of fluorine in urine]G Rausa, R Trivello
Bollettino Dell'Istituto Sieroterapico Milanese|March 31, 1977
Complement fixing antibody to varicella-zoster virus in different age groups and after zosterM E Moschen, A Peserico, R Trivello
Current Pharmaceutical Design|August 5, 2008
Epidemiology of HCV infectionV Baldo, T Baldovin, R Trivello, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1975
[Seroepidemiologic research on the antipoliomyelitic immunity in adult unvaccinated subjects]R Trivello, M E Moschen, M Romano, et al.
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia|November 1, 1977
[Characteristics of the complement-fixing antibody response for varicella-zoster virus in patients with herpes zoster]R Trivello, A Peserico, M E Moschen, et al.
Gerontology|June 22, 2000
Prevalence of antibodies against hepatitis C virus in the elderly: a seroepidemiological study in a nursing home and in an open population. The Collaborative GroupV Baldo, A Floreani, T Menegon, et al.
Vaccine|May 12, 2001
Comparison of three different influenza vaccines in institutionalised elderlyV Baldo, T Menegon, C Bonello, et al.
Journal of Clinical Immunology|May 22, 2007
Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseasesV Baldo, T Baldovin, A Floreani, et al.
Vaccine|March 27, 2007
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complicationsV Baldo, T Baldovin, A Floreani, et al.
Pageof 6